NMDS Group logo

NMDS Group

IPSS-R

IPSS-R Score

Cytogenetic Category
Bone Marrow Blasts (%)
Hemoglobin (mM)
Platelets (109/L)
Neutrophils (109/L)

 

Score Risk category Median OS (years) Median time to 25% AML risk (years)
≤ 1.5 Very low 8.8 NR
2.0 - 3.0 Low 5.3 10.8
3.5 - 4.5 Intermediate 3.0 3.2
5.0 - 6.0 High 1.6 1.4
> 6.0 Very high 0.8 0.73

 

 

 

 

 

 

 

 

Reference: Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454-65

Meetings

Nov
23
NMDSG Fall Meeting 2023
Sigtunastiftelsen

News

Patient information